https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 The role of truncated p53 isoforms in the DNA damage response https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53018 Wed 28 Feb 2024 16:09:22 AEDT ]]> It is not all about the alpha: elevated expression of p53β variants is associated with lower probability of survival in a retrospective melanoma cohort https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53356 Wed 28 Feb 2024 15:24:08 AEDT ]]> p53 Dysregulation in Breast Cancer: Insights on Mutations in the TP53 Network and p53 Isoform Expression https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54539 Tue 27 Feb 2024 20:41:38 AEDT ]]> p53 isoform expression promotes a stemness phenotype and inhibits doxorubicin sensitivity in breast cancer. https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:54475 Tue 27 Feb 2024 14:56:31 AEDT ]]> Cytoplasmic p53β Isoforms Are Associated with Worse Disease-Free Survival in Breast Cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:51863 Thu 21 Sep 2023 10:16:17 AEST ]]> Good cop, bad cop: defining the roles of Δ40p53 in cancer and aging https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:40033 Fri 15 Jul 2022 10:11:14 AEST ]]> The link between aberrations in the p53 pathway and outcomes from DNA-damaging therapies in breast cancer https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:55676 Fri 14 Jun 2024 13:50:00 AEST ]]>